The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus

7 Oct 2022 16:28

RNS Number : 2322C
Maven Income & Growth VCT PLC
07 October 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

Joint Announcement by Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC

Offers for Subscription

7 October 2022

 

The Board of Directors of Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC (together the "Companies" and each a "Company") are pleased to announce that they have published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares of 10p each in each of the Companies to raise, in aggregate, up to £40 million, including over-allotment facilities of up to, in aggregate, £10 million (before issue costs) (the "Offers" and each an "Offer").

The Companies have also published a joint Circular (the "Circular") seeking the approval of their respective shareholders for the allotment and disapplication authorities in connection with the Offers and each Company giving notice of a General Meeting to be held on 9 November 2022 (the "General Meeting").

The Offers will open on 7 October 2022 and the deadline for receipt of applications is 12.00 noon on 4 April 2023 in relation to the tax year 2022/23 and 12.00 noon on 26 May 2023 in relation to the tax year 2023/24. The Offers will close on 31 May 2023 unless the relevant Offer is fully subscribed by an earlier date or previously extended by the relevant Board to no later than 6 October 2023

Each Offer is conditional on the passing of certain resolutions at the relevant General Meeting.

Pursuant to individual offer agreements dated 7 October 2022 relating to each Offer between, among others, each relevant Company and Maven Capital Partners LLP ("Maven"), Maven, as the administrator of each Offer, will receive an offer administration fee of 2.5% of the application amount in relation to each accepted application, with reductions to the offer administration fee applying for applications that benefit from an Early Investment Incentive discount, or as may otherwise be waived by Maven. Maven, as the investment manager of each Company, is a related party of each Company under the Listing Rules, and the payment of such a fee by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

To obtain a copy of the Securities Note, private investors and financial advisers should call Maven on 0141 306 7400. A downloadable version of the Securities Note will shortly be available from the Maven website: www.mavencp.com/vctoffer.

Copies of the Prospectus and Circular are available, free of charge, from Maven at Kintyre House, 205 West George Street, Glasgow G2 2LW.

Copies of the Prospectus have been submitted to the National Storage Mechanism and will shortly be available for viewing online at the following website address: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Any enquiries in respect of the Offers should be directed to:

Maven Capital Partners UK LLPTelephone: 0141 306 7400

E-mail: enquiries@mavencp.com

The information contained within this announcement is deemed by the Companies to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

Notes

 

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIZZMGGKNVGZZM
Date   Source Headline
22nd Nov 20173:01 pmRNSTransaction in Own Shares
21st Nov 20173:45 pmRNSIssue of Equity
17th Nov 20175:09 pmRNSStatement re NAV and Dividend Investment Scheme
9th Nov 20173:58 pmRNSNet Asset Value(s)
8th Nov 201710:10 amRNSResult of General Meeting
25th Oct 20173:00 pmRNSDividend Declaration
18th Oct 201710:43 amRNSReplacement Statement re Listing Application
17th Oct 20172:49 pmRNSStatement re Listing Application
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
15th Sep 20174:48 pmRNSIssue of Equity
15th Sep 201710:08 amRNSStatement re NAV and Dividend Investment Scheme
8th Sep 20177:00 amRNSHalf-year Report
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc
29th Aug 20174:11 pmRNSNet Asset Value(s)
10th Aug 20174:38 pmRNSDividend Declaration
25th Jul 201712:55 pmRNSForm 8.3 - Work Group PLC
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
15th Jun 20174:00 pmRNSDividend Declaration
12th Jun 20174:24 pmRNSTransaction in Own Shares
17th May 20172:33 pmRNSNet Asset Value and Final Dividend
17th May 20172:25 pmRNSResult of AGM
7th Apr 20173:45 pmRNSAnnual Financial Report
2nd Mar 20173:11 pmRNSTransaction in Own Shares
28th Feb 20172:40 pmRNSNet Asset Value and Final Dividend
20th Dec 20164:51 pmRNSTransaction in Own Shares
10th Nov 201611:05 amRNSNet Asset Value(s)
23rd Sep 20165:10 pmRNSTransaction in Own Shares
20th Sep 20164:56 pmRNSTransaction in Own Shares
26th Aug 20164:07 pmRNSHalf-year Report
17th Aug 20162:12 pmRNSNet Asset Value(s)
24th May 20163:06 pmRNSTransaction in Own Shares
27th Apr 20161:50 pmRNSNet Asset Value(s) - Replacement
27th Apr 201612:58 pmRNSResult of AGM
27th Apr 201612:55 pmRNSNet Asset Value(s)
30th Mar 20165:29 pmRNSAnnual Financial Report
22nd Mar 20162:44 pmRNSTransaction in Own Shares
10th Mar 20164:55 pmRNSTransaction in Own Shares
8th Mar 20164:37 pmRNSTransaction in Own Shares
7th Mar 20164:33 pmRNSTransaction in Own Shares
2nd Mar 20164:09 pmRNSNet Asset Value and Proposed Final Dividend
9th Dec 20154:15 pmRNSPortfolio Update and Unaudited Net Asset Value
27th Nov 20154:36 pmRNSTransaction in Own Shares
17th Nov 201512:59 pmRNSTransaction in Own Shares
16th Nov 20152:17 pmRNSTransaction in Own Shares
12th Nov 201510:34 amRNSNet Asset Value(s)
4th Sep 20153:20 pmRNSTransaction in Own Shares
28th Aug 201512:20 pmRNSHalf Yearly Report
24th Aug 20153:39 pmRNSStatement re Dividend Investment Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.